Galapagos is a clinical-stage biotechnology company, specialized in the discovery and development of small molecule medicines with novel.
Industries BiopharmaBiotechnologyClinical TrialsHealth CareMedicalHeadquarters Regions European Union (EU), Europe, Middle East, and Africa (EMEA) Founded Date 1999 Founders Dinko Valerio, Onno Stolpe, Rudi Pauwels Operating Status Active Last Funding Type Post-IPO Equity Legal Name Galapagos NV
Stock Symbol VIE:GLPG Company Type For Profit
Contact Email dpo@glpg.com Phone Number +32 15 34 29 00
Galapagos is a clinical-stage biotechnology company, specialized in the discovery and development of small molecule medicines with novel modes of action. Our ambition is to become a leading global biopharmaceutical company, focused on the discovery, development and commercialization of innovative medicines that will improve people's lives.